Latest Updates



Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen’s COVID-19 Therapeutic Candidate Lenzilumab

Humanigen, a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper response called ‘cytokine storm,’ and Lonza today announced a strategic collaboration to expand the manufacturing capacity for lenzilumab, currently in Phase 3 clinical trials for COVID-19, in advance of potential Emergency Use Authorization in 2020 and subsequent commercialization.

September 16, 2020



SOCMA Acquires Specialty & Custom Chemicals Show

The Society of Chemical Manufacturers & Affiliates (SOCMA) is pleased to announce it is returning to trade show ownership with the acquisition of the Specialty & Custom Chemicals Show, a trade show founded in 2019 and produced by Chemicals America.

September 1, 2020





Pilot Chemical Names Frank D. Nataro as North America Sales Manager

Pilot Chemical Company named Frank D. Nataro as the company’s new North America Sales Manager. Nataro will oversee all sales activities of the North American sales team and will be responsible for developing and executing sales strategy that delivers results in line with Pilot’s growth objectives.

August 4, 2020